Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Sleep Medicine ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- International classification of sleep disorders - third edition (ICSD-3). American Academy of Sleep Medicine, Darien (IL)2014
- The sleepy child.Pediatr Clin North Am. 2004; 51: 15-31
- Evaluation and treatment of children and adolescents with excessive daytime sleepiness.Clin Pediatr. 2020; 59: 340-351
- Validation of the epworth sleepiness scale for children and adolescents using rasch analysis.Sleep Med. 2017; 33: 30-35
- The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children.Sleep. 2003; 26: 455-458
- Development and validation of the pediatric hypersomnolence survey.Neurology. 2022; 98: e1964-e1975
- Prevalence and correlates of hypersomnolence symptoms in US teens.J Am Acad Child Adolesc Psychiatry. 2019; 58: 712-720
- Recommended amount of sleep for pediatric populations: a consensus statement of the american academy of sleep medicine.J Clin Sleep Med. 2016; 12: 785-786
- American academy of sleep medicine: sleep education. Sleep diary.(Available at:) (Accessed June 7, 2022)
- Adolescent sleep patterns, circadian timing, and sleepiness at a transition to early school days.Sleep. 1998; 21: 871-881
- Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.JAMA Neurol. 2013; 70: 891-902
- Searching for a marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy.Sleep. 2008; 31: 1409-1417
- Usefulness of a nocturnal SOREMP for diagnosing narcolepsy with cataplexy in a pediatric population.Sleep. 2015; 38: 859-865
- The spectrum of REM sleep-related episodes in children with type 1 narcolepsy.Brain. 2017; 140: 1669-1679
- Nocturnal REM sleep without atonia is a diagnostic biomarker of pediatric narcolepsy.J Clin Sleep Med. 2018; 14: 245-252
- Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.Sleep Med. 2013; 14: 775-781
- Cataplexy--clinical aspects, pathophysiology and management strategy.Nat Rev Neurol. 2014; 10: 386-395
- The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency.Sleep Med. 2011; 12: 12-18
- Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1.Sleep. 2022; 45: zsac052
- Cataplectic facies: clinical marker in the diagnosis of childhood narcolepsy-report of two cases.Pediatr Neurol. 2014; 50: 515-517
- Cataplexy features in childhood narcolepsy.Mov Disord. 2008; 23: 858-865
- Diagnoses received by narcolepsy patients in the year prior to diagnosis by a sleep specialist.Sleep. 2002; 25: 36-41
- Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.Brain. 2011; 134: 3477-3489
- Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.Sleep. 2012; 35: 1247-1255
- Narcolepsy in African Americans.Sleep. 2015; 38: 1673-1681
- Frequencies and associations of narcolepsy-related symptoms: a cross-sectional study.J Clin Sleep Med. 2015; 11: 1377-1384
- Central disorders of hypersomnolence: focus on the narcolepsies and idiopathic hypersomnia.Chest. 2015; 148: 262-273
- Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study.J Sleep Res. 2013; 22: 482-495
- Schizophrenia-like symptoms in narcolepsy type 1: shared and distinctive clinical characteristics.Neuropsychobiology. 2015; 71: 218-224
- A systematic review of variables associated with sleep paralysis.Sleep Med Rev. 2018; 38: 141-157
- Lifetime prevalence rates of sleep paralysis: a systematic review.Sleep Med Rev. 2011; 15: 311-315
- Lucid dreaming in narcolepsy.Sleep. 2015; 38: 487-497
- Delusional confusion of dreaming and reality in narcolepsy.Sleep. 2014; 37: 419-422
- Clinical and polysomnographic course of childhood narcolepsy with cataplexy.Brain. 2013; 136: 3787-3795
- Disrupted nighttime sleep and sleep instability in narcolepsy.J Clin Sleep Med. 2022; 18: 289-304
- Association of CSF orexin-A levels and nocturnal sleep stability in patients with hypersomnolence.Neurology. 2020; 95: e2900-e2911
- Abnormal sleep/wake dynamics in orexin knockout mice.Sleep. 2010; 33: 297-306
- Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases.Sleep Med. 2014; 15: 262-265
- A comparison of idiopathic hypersomnia and narcolepsy-cataplexy using self report measures and sleep diary data.J Neurol Neurosurg Psychiatr. 1996; 60: 576-578
Maski K., Pizza F., Liu S., et al., Defining disrupted nighttime sleep and assessing its diagnostic utility for pediatric narcolepsy type 1, Sleep, 43 (10), 2020, 1-7.
- Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence.Sleep. 2021; 44
- Disrupted nighttime sleep in narcolepsy.J Clin Sleep Med. 2013; 9: 955-965
- Differences in findings of nocturnal polysomnography and multiple sleep latency test between narcolepsy and idiopathic hypersomnia.Clin Neurophysiol. 2012; 123: 137-141
- Genetic and familial aspects of narcolepsy.Neurology. 1998; 50: S16-S22
- Age at onset of narcolepsy in two large populations of patients in France and Quebec.Neurology. 2001; 57: 2029-2033
- Listening to the patient voice in narcolepsy: diagnostic delay, disease burden, and treatment efficacy.J Clin Sleep Med. 2017; 13: 419-425
- Delayed diagnosis of narcolepsy: characterization and impact.Sleep Med. 2014; 15: 502-507
- The epidemiology of narcolepsy in olmsted county, Minnesota: a population-based study.Sleep. 2002; 25: 197-202
- Prevalence of narcolepsy in king count, Washington, USA.Sleep Med. 2009; 10: 422-426
- Prevalence and incidence of narcolepsy in a US health care claims database, 2008-2010.Sleep. 2019; 42
- Reduced number of hypocretin neurons in human narcolepsy.Neuron. 2000; 27: 469-474
- Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.Nat Rev Neurol. 2019; 15: 519-539
- T cells in patients with narcolepsy target self-antigens of hypocretin neurons.Nature. 2018; 562: 63-68
- Narcolepsy is strongly associated with the T-cell receptor alpha locus.Nat Genet. 2009; 41: 708-711
- Symptoms and occurrences of narcolepsy: a retrospective study of 162 patients during a 10-year period in eastern China.Sleep Med. 2014; 15: 607-613
- Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.Journal Autoimmunology. 2014; : 1-11
- HLA DQB1∗06:02 negative narcolepsy with hypocretin/orexin deficiency.Sleep. 2014; 37: 1601-1608
- Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.Sleep. 2009; 32: 993-998
- A putative link between childhood narcolepsy and obesity.Sleep Med. 2004; 5: 147-150
- High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy.Sleep. 2013; 36: 175-181
- Metabolic profile in patients with narcolepsy: a systematic review and meta-analysis.Sleep Med. 2021; 81: 268-284
- Comorbidities in a community sample of narcolepsy.Sleep Med. 2018; 43: 14-18
- Polysomnographic assessment of sleep comorbidities in drug-naïve narcolepsy-spectrum disorders--a Japanese cross-sectional study.PLoS One. 2015; 10: e0136988
- Attention-deficit/hyperactivity disorder (ADHD) symptoms in pediatric narcolepsy: a cross-sectional study.Sleep. 2015; 83: 1285-1295
- Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population.Sleep Med. 2013; 14: 488-492
- REM sleep behavior disorder and narcoleptic features in Anti–Ma2-associated encephalitis.Sleep. 2007; 30: 767-769
- Clinical analysis of anti-Ma2-associated encephalitis.Brain. 2004; 127: 1831-1844
- Secondary narcolepsy in children.J Child Neurol. 2021; 36: 123-127
- Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.Sleep Med Rev. 2005; 9: 269-310
- Sleep in children with neoplasms of the central nervous system: case review of 14 children.Pediatrics. 2003; 112: e46-e54
- Expanded genetic insight and clinical experience of DNMT1-complex disorder.Neurology Genetics. 2020; 6: e456
- Thinking outside the box: cataplexy without narcolepsy.Sleep Med. 2019; 61: 118-121
- Narcolepsy associated with other central nervous system disorders.Neurology. 2001; 57: 539-541
- Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors.Clin Neurophysiol. 2001; 112: 800-805
- Idiopathic hypersomnia: a study of 77 cases.Sleep. 2007; 30: 1274-1281
- Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients.Sleep. 2009; 32: 753-759
- Waking up is the hardest thing I do all day: sleep inertia and sleep drunkenness.Sleep Med Rev. 2017; 35: 76-84
- Sleep inertia.Sleep Med Rev. 2000; 4: 341-353
- Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness.J Sleep Res. 2010; 19: 525-534
- Hypersomnia with "sleep drunkenness.Arch Gen Psychiatr. 1972; 26: 456-462
- Idiopathic hypersomnia. A series of 42 patients.Brain. 1997; 120: 1423-1435
- Idiopathic hypersomnia.Neurol Clin. 1996; 14: 573-582
- Sleep-wake disorders based on a polysomnographic diagnosis. A national cooperative study.JAMA. 1982; 247: 997-1003
- Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry.Sleep Med. 2020; 75: 343-349
- Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors.Sci Transl Med. 2012; 4: 151
- Absence of γ-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders.Ann Neurol. 2016; 80: 259-268
- Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: a randomized, crossover trial.Ann Neurol. 2015; 78: 454-465
- Flumazenil for the treatment of refractory hypersomnolence: clinical experience with 153 patients.J Clin Sleep Med. 2016; 12: 1389-1394
- Frequency and severity of autonomic symptoms in idiopathic hypersomnia.J Clin Sleep Med. 2020; 16: 749-756
- Diurnal and nocturnal cardiovascular variability and heart rate arousal response in idiopathic hypersomnia.Sleep Med. 2016; 24: 131-136
- Idiopathic Hypersomnia Patients Revealed Longer Circadian Period Length in Peripheral Skin Fibroblasts.Front Neurol. 2018; 9: 424
- Altered dynamics in the circadian oscillation of clock genes in dermal fibroblasts of patients suffering from idiopathic hypersomnia.PLoS One. 2014; 9: e85255
- To split or to lump? Classifying the central disorders of hypersomnolence.Sleep. 2020;
- Test-retest reliability of the multiple sleep latency test in central disorders of hypersomnolence.Sleep. 2017; 40
- The MSLT is repeatable in narcolepsy type 1 but not narcolepsy type 2: a retrospective patient study.J Clin Sleep Med. 2018; 14: 65-74
- Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia.J Clin Sleep Med. 2013; 9: 789-795
- Validation of multiple sleep latency test for the diagnosis of pediatric narcolepsy type 1.Neurology. 2019; 93: e1034-e1044
- Diagnostic and statistical manual of mental disorders : DSM-5. American Psychiatric Association, Arlington, VA2013
Krahn L.E., Arand D.L., Avidan A.Y., et al., Recommended protocols for the Multiple Sleep Latency Test and Maintenance of Wakefulness Test in adults: guidance from the American Academy of Sleep Medicine [published correction appears in J Clin Sleep Med. 2022 Aug 1;18(8):2089]. J Clin Sleep Med. 2021;17(12):2489-2498.
- The neurobiological mechanisms and treatments of REM sleep disturbances in depression.Curr Neuropharmacol. 2015; 13: 543-553
- Sleep as a biomarker for depression.Int Rev Psychiatry. 2013; 25: 632-645
- The influence of antidepressants and actigraphy-derived sleep characteristics on pediatric multiple sleep latency testing.J Clin Sleep Med. 2021; 17: 2179-2185
- Recommended amount of sleep for a healthy adult: a joint consensus statement of the american academy of sleep medicine and sleep research society.Sleep. 2015; 38: 843-844
- Urine toxicology screen in multiple sleep latency test: the correlation of positive tetrahydrocannabinol, drug negative patients, and narcolepsy.J Clin Sleep Med. 2015; 11: 93-99
- Drug testing in children with excessive daytime sleepiness during multiple sleep latency testing.J Clin Sleep Med. 2014; 10: 897-901
- Narcolepsy with long sleep time: a specific entity?.Sleep. 2009; 32: 1229-1235
- Alternative diagnostic criteria for idiopathic hypersomnia: a 32-hour protocol.Ann Neurol. 2018; 83: 235-247
- Optimizing actigraphic estimation of sleep duration in suspected idiopathic hypersomnia.J Clin Sleep Med. 2019; 15: 597-602
- Use of Actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an american academy of sleep medicine systematic review, meta-analysis, and GRADE assessment.J Clin Sleep Med. 2018; 14: 1209-1230
- Consumer sleep technology: an american academy of sleep medicine position statement.J Clin Sleep Med. 2018; 14: 877-880
- HLA DQB1∗0602 is associated with cataplexy in 509 narcoleptic patients.Sleep. 1997; 20: 1012-1020
- Correlation between HLA-DQB1∗06:02 and narcolepsy with and without cataplexy: approving a safe and sensitive genetic test in four major ethnic groups. A systematic meta-analysis.Sleep Med. 2018; 52: 150-157
- Prevalence of the HLA-DQB1∗0602 allele in narcolepsy and idiopathic hypersomnia patients seen at a sleep disorders outpatient unit in São Paulo.Br J Psychiatry. 2009; 31: 10-14
- Measurement of narcolepsy symptoms in school-aged children and adolescents: the pediatric narcolepsy severity scale.Neurology. 2021; 97: e476-e488
- Measurement of symptoms in idiopathic hypersomnia: the idiopathic hypersomnia severity scale.Neurology. 2019; 92: e1754-e1762
- Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.J Clin Sleep Med. 2021; 17: 1881-1893
- Long-term effects of stimulant treatment for ADHD: what can we tell our patients?.Current Developmental Disorders Reports. 2015; 2: 1-9
- Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.Sleep. 2010; 33: 1457-1464
- Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy.J Sleep Res. 2012; 21: 481-483
- Efficacy of modafinil in 10 Taiwanese patients with narcolepsy: findings using the multiple sleep latency test and epworth sleepiness scale.Kaohsiung J Med Sci. 2010; 26: 422-427
- Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.Lancet Child & Adolescent Health. 2018; 2: 483-494
- The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings.Sleep Med. 2014; 15: 522-529
- Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.Lancet Neurol. 2017; 16: 200-207
- Cognitive improvements in children with prader-willi syndrome following pitolisant treatment—patient reports.J Pediatr Pharmacol Therapeut. 2019; 24: 166-171
- Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor.J Pharmacol Exp Ther. 2018; 366: 367-376
- A randomized study of solriamfetol for excessive sleepiness in narcolepsy.Ann Neurol. 2019; 85: 359-370
- Emerging therapeutic targets for narcolepsy.Expert Opin Ther Targets. 2021; : 1-14https://doi.org/10.1080/14728222.2021.1969361
- Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.Lancet Neurol. 2022; 21: 53-65
Article info
Publication history
Published online: March 08, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
